FIELD: medicine.
SUBSTANCE: claimed group of inventions relates to medicine, namely to urology, and deals with treatment of benign hyperplasia of prostate and abacterial prostatitis. For this purpose medication, which contains activated potentiated form of antibodies to prostate-specific antigen and activated potentiated form of antibodies to endothelial NO-synthase, is introduced.
EFFECT: invention provides effective treatment of said urological diseases due to synergic effect of components of medication formulation.
31 cl, 3 ex, 4 tbl
Authors
Dates
2015-10-20—Published
2011-07-01—Filed